Prognostic Value of Immune-Inflammatory Index in PSI IV-V Patients with COVID-19

Table 1

Demographic data, comorbidities, and clinical characteristics of patients ().

Variables	PSI IV-V		value
	Survivors; ()	Nonsurvivors; ()
General demographics
Age (years)			0.013
Sex (female), (%)	8 (42)	3 (33)	>0.999
Comorbidities, (%)
Hypertension	12 (63)	8 (89)	0.214
Diabetes mellitus	5 (26)	4 (44)	0.407
Neoplasm	5 (26)	0 (0)	0.144
Chronic lung disease	9 (47)	1 (11)	0.098
Chronic liver disease	1 (5)	0 (0)	>0.999
Chronic renal disease	2 (11)	2 (22)	0.558
Smoker	4 (21)	2 (22)	>0.999
Alcohol abuser	0 (0)	0 (0)	>0.999
Laboratory
PSI-related variables
pH			0.281
BUN (mmol/L)			0.146
Sodium (mmol/L)			0.978
Glucose (mg/dL)			0.050
Hct (%)			0.795
PaO2 (mmHg)			0.133
Immune-inflammatory index
WBC (/L)			0.439
Neutrophil (/L)			0.172
Lymphocyte (/L)			0.129
NLR			0.033
CRP (mg/L)			0.232
Procalcitonin (ng/mL)			0.022
ICU admission, (%)	2 (11)	6 (67)	0.005

BUN: blood urea nitrogen; CRP: C-reactive protein; Hct: hematocrit; ICU: intensive care unit; NLR: neutrophil-to-lymphocyte ratio; WBC: white blood cell.